What are the opening hours?

Monday 8am - 5pm Tuesday 8am - 5pm Wednesday 8am - 5pm Thursday 8am - 5pm Friday 8am - 5pm

AdventHealth Global Robotics Institute

Home
United States
Celebration, FL
AdventHealth Global Robotics Institute

We are a world class surgical team that provides superior patient outcomes through robot-assisted surgery.

We appreciate and encourage the conversations and perspectives shared by the diverse AdventHealth online community. To ensure this space is safe and welcoming, all visitors are expected to adhere to our community standards, which you can review here: https://www.adventhealth.com/adventhealth-community-standards. Please be advised that any inappropriate, offensive, or hateful comments will be removed by AdventHealth.

12/08/2025

Both Dr. Patel and Dr. Moschovas were recognized at the Translational Research Institute for the most publications this year

12/05/2025

We are grateful for this recognition from
It's an honor to receive the award for Most Publications in 2025, especially in a year where we pushed so hard on innovation, telesurgery, and collaborative research.
This achievement is a reflection of teamwork. None of our work happens alone.
I want to thank our entire GRI Research Department, our clinical and surgical teams, our fellows and students, and all the national and international centers that partnered with us in the multicentric studies we published this year.
Looking forward to continuing this work in 2026 as we keep advancing robotic surgery, digital surgery, and global telesurgery.

12/04/2025

Big congratulations on Dr. Patel's well-earned award at the 2025 AdventHealth Med Staff Excellence Awards Dinner.

11/17/2025

National Influence Award Winner 2025 - Dr. Vipul Patel

11/12/2025

An airman's courage and a surgeon's calling align in life-changing moment

11/11/2025

This morning Dr. Vipul Patel and his team completed their 20,000th robotic prostatectomy! Congratulations, what an accomplishment!

10/24/2025

Today Dr. Patel was invited to show his robotic techniques to WRSE12.

10/23/2025

This year, the NCCN updated its very high-risk criteria to include patients with at least two of the following: PSA > 40, cT3a–b, or Grade Group 4–5. About 35% of very high-risk patients show PSA persistence, indicating a potential need for adjuvant therapy.

Gleason 5+5 shows worse outcomes than 4+5 or 5+4, which may aid in biopsy interpretation.

10/15/2025

Its Medical Assistant Day!

To our incredible MA team, thank you for your dedication, compassion, and the impact you make every single day. Your commitment to patient care, your teamwork, and your resilience do not go unnoticed.

Still here making an impact.

We appreciate you more than words can express. Today, we celebrate YOU!

10/13/2025

Can we truly predict which prostate cancer patients will face recurrence after surgery?
For years, we relied only on clinical and pathological features to stratify risk. But now, with advanced genomic tools, we are entering a new era.
Our recent work with the Decipher genomic classifier shows that patients with a very high-risk score (>0.85) form a distinct subgroup, with significantly worse outcomes after radical prostatectomy. Importantly, when we integrate genomic scores with traditional models like CAPRA-S and EAU risk groups, the ability to predict recurrence becomes much stronger.
🔑 Why this matters:
Patients with very high-risk profiles can be identified earlier.
Treatment planning can be tailored; from surgical approach to adjuvant therapies.
Follow-up can be more personalized, reducing both under- and over-treatment.
This is a step toward precision urology, where combining genomics and clinical data allows us to guide therapy with greater accuracy and ultimately improve outcomes for our patients.
The future of cancer care is not just treating disease, but stratifying patients intelligently to prevent failure before it happens.
For more details, click here...
https://doi.org/10.1016/j.euo.2025.09.009

10/12/2025

Genetics and Prostate Cancer: A New
Perspective in Clinical Research
Roma, Italy I At the Fondazione Policlinico Universitario A. Gemelli IRCCS, a new observational clinical study is going to be launched, focusing on patients with high-risk or locally advanced prostate cancer, as well as those with low-risk disease under active surveillance.
& The aim is to analyze the tumor's genetic profile using next-generation sequencing (NGS) to identify genomic alterations that might be linked to a greater risk of disease progression.
_ A better understanding of these mutations could help, in the future, to tailor treatments more precisely and detect early signs of recurrence.
For those interested in learning more
ClinicalTrials.gov NCT06875297

Address

380 Celebration Place Suite 401
Celebration, FL
34747

Opening Hours

Monday	8am - 5pm
Tuesday	8am - 5pm
Wednesday	8am - 5pm
Thursday	8am - 5pm
Friday	8am - 5pm

Website

http://www.globalroboticsinstitute.com/

Alerts

Be the first to know and let us send you an email when AdventHealth Global Robotics Institute posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Celebration?